Hi, Welcome!

The community is a safe space for people living with and connected to arthritis to ask questions and share experiences. Get started by registering here and posting your first comment or question!

Sign In with a Versus Arthritis account

Reflux query

Tod1Tod1 Posts: 2
edited 30. Jan 2020, 07:01 in Chat to our Helpline Team
I have scleroderma and rheumatoid arthritis. I have reflux issues with a hiatus hernia. I watch my diet carefully and use Gaviscon advance. But I recently spotted a device for sale called an Iqoro (www.iqoro.com) which is a neuromuscular exercise device that claims to be able to fix reflux problems without the need to take medication. It is currently being trialled by a few departments in the NHS and has been looked at by NICE. I was wondering if it might work for arthritis patients with digestive issues. Do you know anything about it?
Many thanks for your help.


  • moderatormoderator Posts: 4,082 mod
    edited 30. Nov -1, 00:00
    Hi Tod1 and welcome to the forum.
    A member of the Helpline Team will be along shortly to help with your request.

    best wishes,

  • helpline_teamhelpline_team Posts: 2,019
    edited 30. Nov -1, 00:00
    I'm sorry to learn of the digestive issues you are experiencing. I have asked our Health Information Team to look into this for you. This is their response:
    - The IQoro is a neuromuscular training device used for improving symptoms related to hiatus hernia by strengthening the oesophagus and diaphragm. It is initially used daily for 3 to 6 months, with follow up maintenance use dependent upon individual need. 
    - It aims to improve long term strength of haitus without long-term medication or surgery.
    - Its intended as an alternative to long-term proton pump inhibitor. But expert reviewer questioned whether it should be used as an adjunct to PPI.
    - Three non-comparative studies (ie., no placebo group) show that IQoro could improve symptoms related to hiatus hernia when used for 6 to 8 months in people with long-term hiatus hernia. Sample sizes were small, no long-term follow-up i.e., lack of evidence for its effectiveness.
    NICE has developed a briefing paper, which includes information on the clinical and technical evidence and specialist commentator comments.
    You can find it here: https://www.nice.org.uk/advice/mib176
    Best wishes
    Mags Helpline Advisor
Sign In or Register to comment.